Advertisement

Psychiatry General

Lipid and Glycemic Profiles in Patients with Bipolar Disorder: Cholesterol Levels Are Reduced in Mania.

Jan 07, 2021

: Bipolar disorder (BD) is a severe mental condition with a lifetime prevalence estimated around 2% among the general population. Due to risk factors, etiological mechanisms, and the chronic use of ps...

Manic and euthymic states in pediatric bipolar disorder patients during an emotional Go/Nogo task: A functional magnetic resonance imaging study.

Jan 07, 2021

Neural abnormalities in emotional response inhibition still exist in the euthymic phase of bipolar disorder (BD). Few studies on comparisons of functional magnetic resonance imaging (fMRI) manifestati...

A person-centered examination of emotion dysregulation, sensitivity to threat, and impulsivity among children and adolescents: An ERP study.

Jan 07, 2021

Adolescence often is characterized by the onset of social anxiety and risk taking; yet, not all youth are anxious and/or risk takers. There are several factors that may help differentiate youth with a...

Effect of residual insomnia and use of hypnotics on relapse of depression: a retrospective cohort study using a health insurance claims database.

Jan 07, 2021

Residual insomnia is associated with a risk of depression recurrence.In this retrospective, longitudinal cohort study, the recurrence pattern of depression in patients with or without residual insomni...

Prescription Opioid Use and Laboratory Value Derangements: A Cross-Sectional Analysis of NHANES Data.

Jan 07, 2021

The use of opioids for the treatment of pain is a risk versus benefit analysis and metabolic disease is an often overlooked variable in the equation and may lead to increased risk of comorbidities of ...

Novel curcumin analog (Cis-Trans Curcumin) as ligand to adenosine receptors A and A: potential for therapeutics.

Jan 07, 2021

All four of the adenosine receptor (AR) subtypes mediate pain and have been targeted by pharmacologists to generate new therapeutics for chronic pain. The vanilloid phytochemicals, which include curcu...

Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis.

Jan 07, 2021

Experience of childhood maltreatment (CM) is a risk factor for opioid use disorder (OUD). CM is also associated with comorbid mental disorders and poor treatment outcomes among people with OUD. To our...

Mobile app-based Remote Patient Monitoring in Acute Medical Conditions: A Prospective Feasibility Study Exploring Digital Health Solutions on Clinical Workload during the COVID Crisis.

Jan 07, 2021

Digital remote patient monitoring (RPM) can add value to virtual wards; this has become more apparent in the context of the COVID-19 pandemic. Healthcare providers are overwhelmed resulting in clinica...

Feasibility study on recycled vegetable oil waste and recycled polyethylene for the modification of aged asphalt.

Jan 07, 2021

The application of reclaimed asphalt pavement has been widely encouraged due to its significant economic and environmental benefits. However, it is necessary to add rejuvenators to ensure its performa...

Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001-2017.

Jan 07, 2021

Currently available data on the prescription practice among patients with major depressive disorder (MDD) reflect the outpatient setting. This is the first study to provide information on time trends ...

mGluR4 Activity Reverses Long-term Outcomes of Morphine Exposure

Jan 05, 2021

Understanding the neurobiological underpinnings of abstinence from drug abuse is critical to better recovery and ensure relapse prevention in addicted subjects. By comparing the long-term transcriptio...

Trajectories of Response to Prefrontal tDCS in MDD

Jan 05, 2021

Transcranial direct current stimulation (tDCS) is a safe, effective treatment for major depressive disorder (MDD). While antidepressant effects are heterogeneous, no studies have investigated trajecto...

Social Cognitive Performance in Schizophrenia vs. Autism

Jan 05, 2021

Schizophrenia spectrum disorders (SSDs) and autism spectrum disorder (ASD) are associated with cognitive disabilities. The two conditions have historically been diagnosed separately using various test...

Youth Depression and Risk of Somatic Diseases and Premature Death

Jan 05, 2021

Several studies have demonstrated that early-onset depression is linked to poor health outcomes. However, whether it is related to specific diseases and premature death is not certain. This study aims...

Risk of Suicide Among Patients With Parkinson Disease

Jan 05, 2021

Parkinson's Disease (PD) is a common neurodegenerative disorder associated with comorbidities and mental disorders. However, recent studies have indicated that PD could be associated with a higher ris...

Differentiating mania/hypomania from happiness using a machine learning analytic approach.

Jan 04, 2021

This study aimed to improve the accuracy of bipolar disorder diagnoses by identifying symptoms that help to distinguish mania/hypomania in bipolar disorders from general 'happiness' in those with unip...

Homegrown perceptions about the medical use and potential abuse of CBD and THC.

Jan 04, 2021

Despite heightened consumer interest in cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC), little is known about public perceptions regarding their medical use and potential for ab...

Suicide in psychiatry and medical liability: A case series.

Jan 04, 2021

The suicide of a patient is a serious event that may constitute a therapeutic failure. To prevent these situations, national and international guidelines exist. When a suicide occurs in a psychiatric ...

Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: much caution is warranted.

Jan 04, 2021

Interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis (IPF) is currently treated with immunosuppressive therapy, with a dynamic algorithm based on continued clinical surveillance. P...

Safinamide in neurological disorders and beyond: evidence from preclinical and clinical studies.

Jan 04, 2021

The discovery and development of safinamide, an alpha-aminoamide, has been a valuable addition to the existing clinical management of Parkinson's disease (PD). The journey of safinamide dates back to ...

SUBSPECIALTIES

Advertisement